CRBU (STOCKS)
Caribou Biosciences, Inc. Common Stock
$1.600000
-0.100000 (-5.88%)
Prev close: $1.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rachel E. Haurwitz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $179.85M
- Employees
- 147
- P/E (TTM)
- -1.13
- P/B (TTM)
- 1.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.24 | $-0.32 | +0.0832 | +25.74% |
|
Mar 2026 (Q1)
|
$-0.26 | $-0.32 | +0.0642 | +19.80% |
|
Dec 2025 (Q4)
|
$-0.28 | $-0.32 | +0.0362 | +11.45% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.37 | +0.0675 | +18.37% |
Financial Statements
| Revenues | $11.20M |
| Benefits Costs and Expenses | $58.46M |
| Costs And Expenses | $140.30M |
| Nonoperating Income/Loss | -$2.06M |
| Operating Expenses | $142.91M |
| Research and Development | $94.52M |
| Other Operating Expenses | $48.40M |
| Operating Income/Loss | -$131.71M |
| Income/Loss From Continuing Operations After Tax | -$133.22M |
| Income/Loss From Continuing Operations Before Tax | -$104.02M |
| Income Tax Expense/Benefit | -$550.00K |
| Net Income/Loss | -$133.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$133.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$133.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.42 |
| Diluted Earnings Per Share | -$1.42 |
| Basic Average Shares | 282,570,118 |
| Diluted Average Shares | 282,570,118 |
| Assets | $149.00M |
| Current Assets | $122.38M |
| Cash | $118.60M |
| Other Current Assets | $3.78M |
| Noncurrent Assets | $26.62M |
| Fixed Assets | $6.12M |
| Other Non-current Assets | $20.49M |
| Liabilities | $46.98M |
| Current Liabilities | $19.67M |
| Accounts Payable | $3.50M |
| Wages | $3.71M |
| Other Current Liabilities | $12.46M |
| Noncurrent Liabilities | $27.31M |
| Equity | $102.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $102.02M |
| Liabilities And Equity | $149.00M |
| Net Cash Flow From Operating Activities | -$101.25M |
| Net Cash Flow From Operating Activities, Continuing | -$101.25M |
| Net Cash Flow From Investing Activities | $76.84M |
| Net Cash Flow From Investing Activities, Continuing | $76.84M |
| Net Cash Flow From Financing Activities | $7.05M |
| Net Cash Flow From Financing Activities, Continuing | $7.05M |
| Net Cash Flow | -$17.36M |
| Net Cash Flow, Continuing | -$17.36M |
| Comprehensive Income/Loss | -$133.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$133.41M |
| Other Comprehensive Income/Loss | -$27.61M |
| Other Comprehensive Income/Loss Attributable To Parent | -$190.00K |